The tweet was deleted by the author.
But we saved everything 🙂.
Cytek Biosciences has released a new on-demand webinar examining how variations in human mesenchymal stem cells (hMSCs) affect downstream applications in regenerative medicine.
The company aims to inform researchers and clinicians that not all hMSCs behave identically, which can have significant consequences for therapeutic development and patient outcomes. The webinar is positioned as a resource for professionals seeking advanced insights into the complexities of cell therapy research, particularly using flow cytometry and immunological tools.
Cytek Biosciences has previously held a webinar on optimizing a 36-color panel for immunophenotyping. The company also announced a separate session unveiling a novel strategy to achieve sterilizing immunity against CDI. These events reflect Cytek’s ongoing focus on advanced flow cytometry and immunological technologies for research applications.